HIV testing during pregnancy, at delivery, and postpartum / lead author, Rodney L. Wright ; with the Medical Care Criteria Committee
Timely diagnosis of HIV and rapid initiation of antiretroviral therapy are crucial to reducing the risk of perinatal HIV transmission and maintaining the health of pregnant patients and their infants. This guideline was developed by the New York State (NYS) Department of Health (DOH) AIDS Institute (AI) to provide evidence-based recommendations regarding HIV testing during pregnancy and at delivery and to promote universal HIV screening for all pregnant patients to achieve the following: Ensure universal HIV screening early in pregnancy, during the third trimester, and during labor for individuals who do not have a documented negative HIV status. Encourage third-trimester testing for syphilis and HIV testing. Encourage HIV testing for pregnant and postpartum patients who exhibit symptoms of acute HIV. Increase uptake of pre-exposure prophylaxis among pregnant patients who do not test positive for HIV but who are at high risk of HIV acquisition during pregnancy and postpartum..
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
[July 2020] |
|---|---|
| Erschienen: |
Baltimore, MD: [Johns Hopkins University] ; July 2020 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wright, Rodney L. [VerfasserIn] |
|---|
| Links: |
www.ncbi.nlm.nih.gov [teilw. kostenfrei] |
|---|
| Themen: |
Anti-Retroviral Agents |
|---|
| Anmerkungen: |
"This guideline was developed by the NYSDOH AI Clinical Guidelines Program, which is a collaborative effort between the NYSDOH AI Office of the Medical Director and the Johns Hopkins University School of Medicine, Division of Infectious Diseases"--PDF page 2. - Includes bibliographical references. - Description based on online resource; title from PDF title page (viewed December 17, 2020) |
|---|
| Umfang: |
1 online resource (1 PDF file (11 pages)) ; illustration |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
1773184652 |
|---|
| LEADER | 01000cam a22002652 4500 | ||
|---|---|---|---|
| 001 | 1773184652 | ||
| 003 | DE-627 | ||
| 005 | 20230428011921.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211011s2020 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)1773184652 | ||
| 035 | |a (DE-599)KEP068718195 | ||
| 035 | |a (NCBI)9917715963406676 | ||
| 035 | |a (EBP)068718195 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wright, Rodney L. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a HIV testing during pregnancy, at delivery, and postpartum |c lead author, Rodney L. Wright ; with the Medical Care Criteria Committee |
| 264 | 1 | |a [Baltimore, MD] |b [Johns Hopkins University] |c [July 2020] | |
| 300 | |a 1 online resource (1 PDF file (11 pages)) |b illustration | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a "This guideline was developed by the NYSDOH AI Clinical Guidelines Program, which is a collaborative effort between the NYSDOH AI Office of the Medical Director and the Johns Hopkins University School of Medicine, Division of Infectious Diseases"--PDF page 2. - Includes bibliographical references. - Description based on online resource; title from PDF title page (viewed December 17, 2020) | ||
| 520 | |a Timely diagnosis of HIV and rapid initiation of antiretroviral therapy are crucial to reducing the risk of perinatal HIV transmission and maintaining the health of pregnant patients and their infants. This guideline was developed by the New York State (NYS) Department of Health (DOH) AIDS Institute (AI) to provide evidence-based recommendations regarding HIV testing during pregnancy and at delivery and to promote universal HIV screening for all pregnant patients to achieve the following: Ensure universal HIV screening early in pregnancy, during the third trimester, and during labor for individuals who do not have a documented negative HIV status. Encourage third-trimester testing for syphilis and HIV testing. Encourage HIV testing for pregnant and postpartum patients who exhibit symptoms of acute HIV. Increase uptake of pre-exposure prophylaxis among pregnant patients who do not test positive for HIV but who are at high risk of HIV acquisition during pregnancy and postpartum. | ||
| 650 | 2 | |a HIV Testing |0 https://id.nlm.nih.gov/mesh/D000082922 | |
| 650 | 2 | |a Pregnancy |0 https://id.nlm.nih.gov/mesh/D011247 | |
| 650 | 2 | |a Anti-Retroviral Agents |x therapeutic use |0 https://id.nlm.nih.gov/mesh/D044966Q000627 | |
| 650 | 2 | |a HIV Infections |x diagnosis |0 https://id.nlm.nih.gov/mesh/D015658Q000175 | |
| 650 | 2 | |a Infectious Disease Transmission, Vertical |x prevention & control |0 https://id.nlm.nih.gov/mesh/D018445Q000517 | |
| 650 | 2 | |a Pregnancy Complications, Infectious |x prevention & control |0 https://id.nlm.nih.gov/mesh/D011251Q000517 | |
| 651 | 2 | |a New York |0 https://id.nlm.nih.gov/mesh/D009518 | |
| 655 | 2 | |a Practice Guideline |0 https://id.nlm.nih.gov/mesh/D017065 | |
| 710 | 2 | |a New York (State). |b AIDS Institute. |e VerfasserIn |4 aut | |
| 710 | 2 | |a Clinical Guidelines Program, |e MitwirkendeR |4 ctb | |
| 856 | 4 | 0 | |u https://www.ncbi.nlm.nih.gov/books/NBK560463/ |m X:NCBI |x Verlag |z teilw. kostenfrei |
| 912 | |a ZDB-193-NCB | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a ISIL_DE-18 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_22_i06404 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a ISIL_DE-7 | ||
| 912 | |a GBV_ILN_74 | ||
| 912 | |a ISIL_DE-354 | ||
| 912 | |a GBV_ILN_2003 | ||
| 912 | |a ISIL_DE-25 | ||
| 912 | |a GBV_ILN_2009 | ||
| 912 | |a ISIL_DE-180 | ||
| 912 | |a GBV_ILN_2010 | ||
| 912 | |a ISIL_DE-15 | ||
| 951 | |a BO | ||
| 980 | |2 22 |1 01 |x 0018 |b 3994081726 |h h64 NCBI |y zi06404 |z 21-10-21 | ||
| 980 | |2 40 |1 01 |x 0007 |b 3994007976 |h OLR-NCB-BOOKSHELF |y xsn |z 21-10-21 | ||
| 980 | |2 74 |1 01 |x 0354 |b 3999784253 |c 09 |f E-Bibl |d EM 0000 |e --%%-- |j --%%-- |y ze |z 08-11-21 | ||
| 980 | |2 2003 |1 01 |x DE-25 |b 3995674046 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Elektronischer Volltext - Open Access |y l01 |z 25-10-21 | ||
| 980 | |2 2009 |1 01 |x DE-180 |b 3987674237 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 11-10-21 | ||
| 980 | |2 2010 |1 01 |x DE-15 |b 3987760354 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Elektronischer Volltext - Open Access |y l01 |z 11-10-21 | ||
| 981 | |2 22 |1 01 |x 0018 |r https://www.ncbi.nlm.nih.gov/books/NBK560463/ | ||
| 981 | |2 40 |1 01 |x 0007 |y Volltext, Open Access |r https://www.ncbi.nlm.nih.gov/books/NBK560463/ | ||
| 981 | |2 74 |1 01 |x 0354 |r https://www.ncbi.nlm.nih.gov/books/NBK560463/ | ||
| 981 | |2 2003 |1 01 |x DE-25 |r https://www.ncbi.nlm.nih.gov/books/NBK560463/ | ||
| 981 | |2 2010 |1 01 |x DE-15 |y Online-Zugriff |r https://www.ncbi.nlm.nih.gov/books/NBK560463/ | ||
| 985 | |2 22 |1 01 |x 0018 |a h64 ebook | ||
| 985 | |2 74 |1 01 |x 0354 |a EM 0000 | ||
| 995 | |2 22 |1 01 |x 0018 |a h64 NCBI | ||
| 995 | |2 22 |1 01 |x 0018 |a h64 freie Ressource | ||
| 995 | |2 40 |1 01 |x 0007 |a OLR-NCB-BOOKSHELF | ||